Shuttle Pharmaceuticals Holdings, Inc. (SHPH): Total Liabilities
$8.22M
As of 2025-12-31
$3.63M
As of 2026-06-30
+103.5%
3-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $8.22M | +357.5% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $1.80M | -5.2% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $1.90M | +94.3% | 2025-02-26, Balance as of period end |
| 2022-12-31 | $975.7K | -57.2% | 2024-09-04, Balance as of period end |
| 2021-12-31 | $2.28M | n/a | 2023-03-15, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | 2025-12-31 | $8.22M | +357.5% |
| Traws Pharma, Inc. (TRAW) | 2025-12-31 | $11.25M | -80.1% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $4.59M | +24.9% |
| Genprex, Inc. (GNPX) | 2025-12-31 | $2.20M | -12.3% |
| Oragenics Inc (OGEN) | 2025-12-31 | $1.79M | +6.1% |
| Medicus Pharma Ltd. (MDCX) | 2025-12-31 | $10.02M | +299.0% |
| Lantern Pharma Inc. (LTRN) | 2025-12-31 | $4.50M | +2.7% |
| Lunai Bioworks Inc. (LNAI) | 2026-06-30 | $18.97M | -35.9% |
| Decoy Therapeutics Inc. (DCOY) | 2025-12-31 | $5.17M | +241.9% |
Compare SHPH, TRAW, LGVN, GNPX side by side · Screen every company in Pharmaceutical Preparations ↗